Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant-activated human neutrophils: A potential strategy to control neutrophil-mediated inflammation

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages

  Steel, H C ^a   Theron, A J ^a   Tintinger, G R ^a   Anderson, R ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

5 lipoxygenase; Clarithromycin; FMLP; Itraconazole; Platelet activating factor

Indexed keywords

CALCIUM ION; CLARITHROMYCIN; FURA 2 ACETOXYMETHYL ESTER; ITRACONAZOLE; LEUKOTRIENE B4; POSACONAZOLE; THROMBOCYTE ACTIVATING FACTOR; ANTIINFLAMMATORY AGENT; CALCIUM; IMMUNOLOGIC FACTOR; TRIAZOLE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PROTEIN SECRETION; SEPSIS; SPECTROFLUOROMETRY; ADULT; DRUG EFFECT; IMMUNOASSAY; IMMUNOLOGY; METABOLISM; METHODOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; CALCIUM; HUMANS; IMMUNOASSAY; IMMUNOLOGIC FACTORS; LEUKOTRIENE B4; NEUTROPHILS; PLATELET ACTIVATING FACTOR; SPECTROMETRY, FLUORESCENCE; TRIAZOLES; YOUNG ADULT;

EID: 73949124495     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp329     Document Type: Article

References (33)

1. Annane D, Bellissant E, Cavaillon J-M. Septic shock. Lancet 2005; 365: 63-78.
2. Brown KA, Brain SD, Pearson JD et al. Neutrophils of multiple organ failure in sepsis. Lancet 2006; 368: 157-69.
3. Moreno SE, Alves-Filho JC, Rios-Santos F et al. Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. J Immunol 2006; 177: 1264-71.
4. Strickland I, Kisich K, Hauk PJ et al. High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001; 193: 585-93.
5. 4 receptor-1 expression during neutrophilic differentiation of HL-60 cells. Biochem Biophys Res Comm 2003; 309: 114-9.
6. + T cells are accompanied by increased IL-2 receptor expression. J Allergy Clin Immunol 2008; 121 Suppl 1: S115.
7. Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 2007; 119: 7-13.
8. Shinkai M, Foster GH, Rubin BK. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L75-85.
9. Verleden GM, Vanaudenaerde BM, Du Pont LJ et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 174: 566-70.
10. Williams JG, Maier RV. Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome). Surgery 1992; 112: 270-2.
11. Merlos M, Vericate ML, Garcia-Rafanell J et al. Topical antiinflammatory properties of flutrimazole, a new imidazole antifungal agent. Inflamm Res 1996; 45: 20-5.
12. Steel HC, Anderson R. Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils. Clin Exp Immunol 2004; 136: 255-61.
13. 4. Clin Exp Immunol 2007; 150: 144-50.
14. Giamarellos-Bourboulis EJ, Pechère J-C, Routsi C et al. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008; 46: 1157-64.
15. Restrepo MI, Mortensen EM, Waterer GW et al. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Resp J 2009; 33: 153-9.
16. Slotman GJ, Burchard KW, D'Arezzo A et al. Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 1988; 28: 648-54.
17. Yu M, Tomassa G. A double-blind, prospective randomised trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993; 21: 1635-42.
18. Sinuff T, Cook DJ, Peterson JC et al. Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis. J Crit Care 1999; 14: 1-6.
19. Jacobs S, Price Evans DA, Tariq M et al. Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 2003; 31: 1938-46.
20. The ARDS Network. Ketoconazole for early treatment of acute respiratory distress syndrome: a randomised controlled trial. JAMA 2000; 283: 1995-2002.
21. Steel HC, Tintinger GR, Anderson R. Comparison of the antiinflammatory activities of imidazole antimycotics in relation to molecular structure. Chem Biol Drug Des 2008; 72: 225-8.
22. Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract 2004; 58: 612-24.
23. Courtney R, Radwanski E, Lim J et al. Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men. Antimicrob Agents Chemother 2004; 48: 804-8.
24. Kageyama S, Masuya M, Tanaka I et al. Plasma concentration of itraconazole and its antifungal prophylactic efficacy in patients with neutropenia after chemotherapy for acute leukaemia. J Infect Chemother 1999; 5: 213-6.
25. Kees F, Wellenhofer M, Grobecker H. Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. Infection 1995; 23: 168-72.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3340-50.
27. 2+ influx in human neutrophil granulocytes: alterations in chronic granulomatous disease. J Biol Chem 1997; 272: 2641-48.
28. Quinn JV, Slotman GJ. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Crit Care Med 1999; 27: 2485-94.
29. 4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Crit Care Med 2000; 28: 57-62.
30. Bulger EM, Arbabi S, Garcia I et al. The macrophage response to endotoxin requires platelet-activating factor. Shock 2002; 17: 173-9.
31. Bagshaw SM, Langenberg C, Haase M et al. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007; 33: 1285-96.
32. Steel HC, Anderson R. Dissociation of the PAF receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. Br J Pharmacol 2002; 136: 81-9.
33. Tkacz JS, DiDomenico B. Antifungals: what's in the pipeline. Curr Opin Microbiol 2001; 4: 540-5.